Company Profile

InviCRO LLC
Profile last edited on: 12/14/2017      CAGE: 5E2R8      UEI: NCNZRA2WSKC5

Business Identifier: Imaging informatics: full-service tissue-to-human imaging, analysis, and data management services
Year Founded
2008
First Award
2010
Latest Award
2014
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

27 Drydock Avenue Suite 7
Boston, MA 02210
   (617) 904-2100
   info@invicro.com
   www.invicro.com
Location: Single
Congr. District: 08
County: Suffolk

Public Profile

inviCRO began operations as an image science company providing advanced data analysis services and software in the growing field of pre-clinical imaging research. More recently Invicro expanded its offering in clinical phase research with the acquisition of Molecular Neuroimaging, LLC in 2016 and Imanova Ltd. in 2017. Invicro develops and leverages the latest approaches in quantitative biomarker research. The successful integration of the discovery and clinical teams onto InvicroÂ’s industry-leading software informatics platforms. Invicro is now better described as providing imaging services to the pharmaceutical and biotechnology industry from early phase discovery through late-phase clinical trials having built these services on a software and analytics platform enabling streamlined large-scale data analytics across any quantitative biomarker readout. In September 2017, it was announced that Konica Minolta, Inc.-- a global digital technology company with core strengths in imaging and data analysis, optics, materials, and nano-fabrication - had acquired InviCRO LLC with a view to Konica Minolta accelerating their won expansion into precision medicine business .

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 NIH $2,636,066
Project Title: Development of a Kit Based Pet Molecular Imaging Agent: Edotreotide Ga 68 for So

Key People / Management

  John Hoppin -- Co-Founder & Ceo

  James F Kronauge

  Christian Lackas -- Co-Founder & Managing Partner

  Janna Murgia -- Co-Founder & Coo